An explanation of siRNA and ASO patent trends and patent cliffs from the perspectives of intellectual property and CMC.
This seminar will explain the entry strategies for nucleic acid medicines, covering the basics and manufacturing management of RNA medicines, landscape based on patent analysis, the patent history of siRNA and ASO, the patent status of DDS such as GalNAc and LNP, major lawsuits and licensing strategies, and the Patent Cliff of platform technologies from 2020 to 2035. Based on the RNA medicine value chain and entry models, the goal is to acquire a framework to determine when and what your company can utilize. *For more details, please check the related links or the seminar details in the catalog.*
Inquire About This Product
basic information
<Event Information> Format: Online lecture via Zoom Date and Time: July 16, 2026 (Thursday) 10:00 AM - 4:30 PM Participation Fee: 52,800 yen (tax included) Instructors: Kunihoshi Kiba, Satoshi Suzuki
Price range
Delivery Time
Applications/Examples of results
<Seminar Program (Tentative)> Chapter 1: Introduction: The RNA Medicine Revolution Chapter 2: Basics of RNA Medicine Chapter 3: RNA Medicine CMC Chapter 4: Basic Structure of Nucleic Acid Medicine Patents Chapter 5: History of siRNA Patents Chapter 6: History of ASO Patents Chapter 7: DDS Patent Competition Chapter 8: RNA Medicine Patent Landscape Chapter 9: Patent Disputes and Licensing Strategies Chapter 10: Patent Cliff Chapter 11: Structure of the RNA Medicine Industry Chapter 12: Entry Strategies for RNA Medicine Chapter 13: Conclusion: The Future of the RNA Medicine Industry
catalog（1）
Download All Catalogs
Company information
We support Japan's "monozukuri" (manufacturing) with reliable services ranging from patent research and other intellectual property business solutions to technical translation services and intellectual property/engineer education. We offer high-quality services backed by over 40 years of experience at reasonable prices.
